Single-specialty interventional pain management chain Nivaan Care has raised USD 7 million in a Series A funding round led by Sorin Investments, marking a key milestone in its growth journey.
Additionally, existing investors W Health Ventures, Endiya Partners, and Rebright Partners also participated in the round, reaffirming their confidence in the company’s model and execution.
With this fresh capital, the Delhi-based health-tech startup plans to expand its clinic network across multiple Indian cities. At the same time, the company aims to strengthen its clinical and operational infrastructure and further develop minimally invasive pain management procedures.
This round follows Nivaan Care’s USD 4.25 million seed funding raised in February 2025, which Endiya Partners led with participation from W Health Ventures. Together, these investments significantly enhance the company’s ability to scale its specialized care delivery model.
Founded in 2023 by Nivesh Khandelwal and Vishwas Singh, Nivaan Care focuses on non-surgical and minimally invasive treatments for chronic pain. The startup operates single-specialty clinics that address conditions such as back, knee, and neck pain through a multidisciplinary care model.
Notably, Nivaan Care brings together pain physicians, physiotherapists, psychologists, nutritionists, and care coordinators, who collaborate to deliver personalized treatment plans. Currently, the company operates clinics across Delhi-NCR and Mumbai, while also serving satellite markets such as Jaipur and Lucknow.
According to the startup, it has already completed over 40,000 patient consultations and performed around 5,000 minimally invasive procedures. Moreover, a significant proportion of patients have reported noticeable pain reduction and improved daily functioning following treatment.
“Chronic pain affects nearly one in five adults in India, yet care delivery remains fragmented, often oscillating between basic physiotherapy and invasive surgery,” said Nivesh Khandelwal, co-founder and CEO of Nivaan Care. He added, “At Nivaan, we are building a dedicated, evidence-led middle layer of care that focuses on minimally invasive interventions, such as radiofrequency ablation and platelet-rich plasma therapy, delivered through a multidisciplinary model.”
Meanwhile, Vishwas Singh, co-founder and COO, emphasized operational rigor as the company scales. “As we scale, our focus is on execution excellence, strong operating systems, and seamless patient journeys across locations,” he said, while also noting that the company plans to enter new markets, including Bengaluru.
Importantly, the founding team brings deep experience in scaling healthcare and consumer-focused businesses. Previously, Khandelwal served as chief operating officer at Ridge IVF, while Singh held leadership roles at Tata 1mg and Shuttl, equipping them with operational and consumer-tech expertise.
Overall, Nivaan Care’s latest funding round positions it strongly to address India’s growing chronic pain burden through specialized, minimally invasive, and evidence-led care. As the company expands into new cities and refines its operating model, it aims to emerge as a leading national platform in interventional pain management.
